We can summarize that hormone replacement therapy was able to ameliorate the metabolic parameters, except for the cholesterol values of aged rats where testosterone treatment did not mitigate the castration-induced adverse changes. As expected, testosterone deficiency caused by aging or surgical castration resulted in a significant increase in the inflammatory processes, as shown by the elevation of the MPO activity. Similarly, in the aging groups with a lower testosterone level, the cardiac cGMP levels were significantly lower compared to the young/fertile SO rats. (A) The effects of aging, surgical castration, and testosterone replacement therapy on the cardiac HO activity (HO; expressed as nmol bilirubin/h/mg protein). Treatment with testosterone undecanoate resulted in the restoration of the androgen level in young animals, and caused a further enhancement in the case of aged animals. As expected, the hormone level was significantly reduced by the aging process, and it was undetectable in the castrated (CAS and CAS + Cypr) groups. The aim of our work is to study the association between the testosterone level and oxidative/inflammatory processes in male rats subjected to testosterone deprivation (young castrated and aged rats) and testosterone replacement. A total amount of ∼200 mg muscle was aspirated, and biopsies were cleaned for blood (within 15 s) and snap frozen in liquid nitrogen. Subsequently, labeled VLDL particles were separated from other particles in plasma by 18 h of ultracentrifugation at 98,350g and 4°C. We used approximately one-fifth of total tracer available as priming bolus. In non-human primates, it may be that testosterone in puberty stimulates sexual arousal, which allows the primate to increasingly seek out sexual experiences with females and thus creates a sexual preference for females. The reflexive testosterone increases in male mice is related to the male's initial level of sexual arousal. In women, correlations may exist between positive orgasm experience and testosterone levels. In order to minimize carryover and period effects, each of the four treatment modalities were equally distributed throughout the 12 treatment series, in random order, and with at least 1-month intervals between sessions. T gel has previously been shown to result in normophysiological plasma T levels within 2–3 h (27). Thus, hypogonadal trial days were preceded by at least 7–10 days of castrate levels of T, designed to achieve stable changes in their metabolic state. Therefore, gonadotropins and T levels were measured 1 week before trial days, and volunteers that did not present with castrate levels of T at this point were reinjected with GnRH agonist and the session was postponed. Recently, however, overweight hypogonadal patients were shown to store more meal-derived free fatty acids (FFAs) in fat depots and have lower 6-h postabsorptive fat oxidation than BMI-matched controls (14). In recent years, interest in testosterone (T) has been increasing due to the accumulating evidence associating low T levels in men with augmented endocrine and cardiovascular morbidity and mortality (1–3). Testosterone levels for T150 (hypogonadal + 150 mg T substitution, ○), T50 (hypogonadal + 50 mg T substitution, ●), P (placebo, □), and C (control, ■) during trial days. Real-time PCR for target genes was performed with mRNA levels of β2-microglobulin as internal control. Visceral FM was determined manually after placement of a region of interest from L2 to L4 and laterally extending to the outer rim of the rib cage (30), an area shown to contain predominantly visceral adipose tissue (31).